Dyne Therapeutics Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing…
Pharmaceuticals, Biotechnology and Life Sciences
WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing…
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement BEDFORD,…
LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on…
-Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave- WALTHAM, Mass., Jan. 03, 2024 (GLOBE…
Monthly information related to total number of voting rights and shares composing the share capital _ December 31, 2023 Article…
SEATTLE, Jan. 03, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for…
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology…
HANOVER, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical…
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”),…
LAS VEGAS, Dec. 28, 2023 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX, HYEXD), a platform for acquiring, developing, patenting,…